USA Animal Model Industry is forecasted to achieve a value surpassing US$ 1,487.9 Million by 2033 as per the FMI Report

USA Animal Model Industry

The USA animal model industry size witnessed a valuation of approximately US$ 976.1 million in 2023, marking a significant milestone in biomedical research and development. Projections indicate a robust growth trajectory, with an anticipated Compound Annual Growth Rate (CAGR) of 4.3% from 2023 to 2033. The demand for animal models within the USA is slated to surge, with an estimated value reaching US$ 1,487.9 million by 2033, according to a comprehensive study by Future Market Insights.

The study highlights the pivotal role of animal models in various research domains, emphasizing their crucial contribution to scientific advancements and innovative breakthroughs. Mice emerged as a dominant species within the USA market, holding a substantial share of over 61.03% in 2022. Their versatile nature and genetic proximity to humans have rendered them invaluable assets in preclinical trials and biomedical studies, fueling their widespread utilization across research laboratories.

Get your report sample to gain comprehensive insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

The projected growth signifies a burgeoning demand for sophisticated research methodologies and the continual pursuit of advancements in the biomedical sector. Leveraging animal models remains indispensable for developing novel therapies, understanding disease mechanisms, and facilitating the progress of pharmaceutical and biotechnological innovations.

“This substantial growth in the USA animal model market underscores the indispensable role of these models in driving scientific progress,” stated a representative from Future Market Insights. “The anticipated rise reflects the ongoing commitment of the biomedical community toward fostering innovative research methodologies and advancing medical breakthroughs.”

As the USA animal model market expands, stakeholders within the biomedical and pharmaceutical industries are poised to embrace new opportunities, fostering collaborations, and investing in cutting-edge technologies to further enhance research outcomes.

Key Takeaways from the USA Animal Model Market Study Report:

• Back in the year 2017, the demand for animal models in the United States, in terms of value, was nearly 818.7 million.
• Over the next ten years, the animal model market in the United States is projected to witness an absolute growth of US$ 540.6 million.
• Based on different species types, mice are the most preferred models and acquire a market share of 61.03% in the United States.
• Among the different end-user verticals, most of the demand for animal-based models comes from academic and research institutes. This segment generated a revenue of around US$ 352.5 million in 2022, which was figured out to be 37.21% of the market.

Reach Out To Our Analyst For Prompt Assistance With Your Questions! https://www.futuremarketinsights.com/ask-question/rep-gb-14527

Competitive Landscape for the USA Animal Model Market Players:

Key firms in the market are using strategic formulations including forward integration, global expansion, and research alliances to maximize their revenue share and foster business growth. As there are many established participants in the supply of animal models, the overall USA market is fairly distributed and fragmented. However, the market is somewhat consolidated by large investments made by the DARPA and National Institutes of Health in the last few years.

Recent Developments by the Animal Model Industries based in the USA:

• The Jackson Laboratory Inc. reported in February 2020 that a specific hACE2 genetically altered mouse model was available to aid COVID-19 research. This change presented fresh chances to create cutting-edge transgenic mice study models for the best results in clinical studies.
• Charles River Laboratories Inc. and genOway, which is a biotechnology research company that creates transgenic research models, announced their alliance in May 2018. 2000 Ready-to-Use Knockout Mouse Models were to be made available through this agreement for in vivo research projects. The firm was able to strengthen its market position and obtain an edge over others after this strategic relationship.

Key Companies Profiled:

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• Genoway
• Envigo (Inotiv, Inc.)
• Marshall BioResources
• Janvier Labs
• Applied stem cells
• Biocytogen
• Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
• Cyagen
• Ingenious targeting labs
• Crown Bioscience Inc. (JSR Corporation).
• Harbour Biomed
• Sinclair BioResources
• Alpha Genesis Inc.
• Creative Animodel
• DaVinci Biomedical Research Products, Inc

Discover the Future of Marketing: Get Your Hands on Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-14527

Key Segments Covered by USA Animal Model Industry Survey Report:

By Species:

• Mice
• Rats
• Fish
• Birds
• Cattles
• Pigs
• Amphibians
• Guinea Pigs
• Dogs
• Cats
• Rabbits
• Monkeys
• Sheep
• Hamsters
• Other Animals

By Technology:

• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• Microinjection
• Nuclear Transfer
• Other Technologies

By Application:

• Research & Development
  • Infectious Disease
  • Immunological Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Genetic Diseases
  • Neurological Diseases
  • Obesity
  • NAFLD or NASH
  • Renal disease
  • Diabetic eye disease
  • Fibrosis
  • Micro-biome
  • Other Research and Developments
• Production and Quality Control
• Academics
• Preclinical Applications
  • Infectious Disease
  • Immunological Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Genetic Diseases
  • Neurological Diseases
  • Obesity
  • NAFLD/NASH
  • Renal disease
  • Diabetic eye disease
  • Fibrosis
  • Micro-biome
  • Other Preclinical Applications
• Other Applications

By Use:

• Human
• Veterinary

By End-user Verticals:

• Companies
  • Pharmaceutical
  • Biotechnology
  • Cosmetics
  • Other Companies
• Organizations
  • Government
  • Non-government
• Academic and Research Institutes
• Contract Research Organizations (CRO)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube